Gaining Stocks Protagonist Therapeutics (NASDAQ: PTGX) Rallies after Announcing PTG-300 Phase 2 Trial Initial Results Protagonist Therapeutics Inc (NASDAQ: PTGX) was one of the top gainers in Wednesday’s trading session. The stock rallied to close the day with gains of 72.92%. This came a day after it announced early results for its ongoing phase 2 study for